Financially troubled PET developer Positron appears to be making progress with its revival plans. The Houston-based firm has received approval from the Japanese Ministry of Health & Welfare for its Posicam-HZ Series PET scanner. The Posicam scanners
Financially troubled PET developer Positron appears to be making progress with its revival plans. The Houston-based firm has received approval from the Japanese Ministry of Health & Welfare for its Posicam-HZ Series PET scanner. The Posicam scanners will be marketed and distributed in Japan exclusively by Imatron Japan, an independent distributor in which ultrafast CT developer Imatron maintains a 24% equity stake. Imatron, of South San Francisco, CA, took over as controlling shareholder in Positron earlier this year (SCAN 2/3/99).
Upon completion of an expected major third-party equity financing deal, Positron will be well positioned to take advantage of PET market opportunities in Japan and the U.S., said Imatron CEO Lewis Meyer. Imatron hopes that the 24 Japanese customers of Imatrons ultrafast CT scanner will be interested in utilizing PET and ultrafast CT as complementary imaging modalities.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.